PCI The Journeys Within

Current Edition

Frankfurt 2027 – 12/10/26
ramusmedical
Europe

Educational campaign helps teens and their caregivers tackle the everyday challenges of living with moderate-to-severe atopic dermatitis

Teenagers face many challenges, and growing up with a chronic skin disease called atopic dermatitis (AD) can impact the ups and downs and transitions to young adult...
Continue Reading →
Europe

AstraZeneca amends collaboration with Ironwood for Linzess in China

AstraZeneca has amended its collaboration agreement with Ironwood Pharmaceuticals, Inc. (Ironwood) in China mainland, China Hong Kong and China Macau for Linzess ...
Continue Reading →
Europe

Dengue virus becoming resistant to vaccines and therapeutics due to mutations in specific protein

Researchers from Duke-NUS Medical School (DukeNUS), in collaboration with the Agency for Science, Technology and Research (A*STAR)'s Bioinformatics Institute (BII),...
Continue Reading →
Europe

FDA approves first oral GLP-1 treatment for type 2 diabetes

FDA The U.S. Food and Drug Administration today approved Rybelsus (semaglutide) oral tablets to improve control of blood sugar in adult patients with type 2 diabe...
Continue Reading →
Europe

Andaman7 and Oncology Information Service Announce Partnership to Generate Patient-centered Views into Cancer Treatments in Europe

Freiburg, Germany/Brussels, Belgium, September 10th, 2019. Andaman7 and OncologyInformationService Announce Partnership to Generate Patient-centered Views into ...
Continue Reading →
Europe

FDA grants Fast Track designation for Farxiga in heart failure

AstraZeneca announced that the US Food and Drug Administration (FDA) has granted Fast Track designation for the development of Farxiga (dapagliflozin) to reduce the...
Continue Reading →
Europe

FDA takes first action under new international collaboration with Australia and Canada

The U.S. Food and Drug Administration is announcing Project Orbis, an initiative of the FDA Oncology Center of Excellence (OCE). Project Orbis provides a framework ...
Continue Reading →
Europe

Abbott announces new data that shows artificial intelligence technology can help doctors better determine which patients are having a heart attack

Abbott (NYSE: ABT) announced that new research, published in the journal Circulation, found its algorithm could help doctors in hospital emergency rooms more accura...
Continue Reading →
Europe

A promising treatment for an incurable, deadly kidney disease

A potential treatment for polycystic kidney disease - a genetic disorder that causes the kidneys to swell with multiple cysts and can eventually lead to organ failu...
Continue Reading →
Europe

Roche presents new 6-year OCREVUS (ocrelizumab) data which showed that earlier initiation and continuation of treatment reduced disability progression in multiple sclerosis

Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced longer-term data from the Phase III open-label extension studies of OPERA I, OPERA II and ORATORIO showed that pa...
Continue Reading →
Quotient